Subscribe To
: lexeo therapeutics’ stock falls 15% in trading debut after its ipo priced below range
Lexeo therapeutics Inc.’s stock LXEO tumbled 15% in its trading debut on Friday, after the company’...
November 4, 2023, 4:29 pm
Kymera therapeutics, inc. (kymr) q3 2023 earnings call transcript
Kymera therapeutics, Inc. (NASDAQ:KYMR ) Q3 2023 Earnings Call Transcript November 2, 2023 8:00 AM ET C...
November 4, 2023, 1:10 pm
Candel therapeutics presents preclinical data from its enlighten™ discovery platform at sitc
The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate...
November 4, 2023, 12:00 pm
Seres therapeutics, inc. (mcrb) q3 2023 earnings call transcript
Seres therapeutics, Inc. (NASDAQ:MCRB ) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Com...
November 4, 2023, 11:52 am
Atara biotherapeutics, inc. (atra) q3 2023 earnings call transcript
Atara Biotherapeutics, Inc. (NASDAQ:ATRA ) Q3 2023 Results Conference Call November 1, 2023 9:00 AM ET ...
November 4, 2023, 11:45 am
Lisata therapeutics, inc. (lsta) q3 2023 earnings call transcript
Lisata therapeutics, Inc. (NASDAQ:LSTA ) Q3 2023 Results Conference Call November 2, 2023 4:30 PM ET Co...
November 4, 2023, 10:27 am
1 under-the-radar stock that could triple by 2030
Viking therapeutics is looking to profit from the expanding market for obesity drugs. The company's two...
November 4, 2023, 7:30 am
Shareholder investigation: halper sadeh llc investigates miro, src, doc
NEW YORK, Nov. 04, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
November 4, 2023, 4:00 am
Otlk investor alert: robbins geller rudman & dowd llp announces that outlook therapeutics, inc. investors with substantial losses have opportunity to lead the outlook therapeutics class action lawsuit
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that the Outlook ther...
November 4, 2023, 12:13 am
Autolus therapeutics plc (autl) q3 2023 earnings call transcript
Autolus therapeutics plc (NASDAQ:AUTL ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Co...
November 3, 2023, 10:05 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data
November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos ...
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting
– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...
November 3, 2023, 8:05 pm
Update: korro bio and frequency therapeutics announce closing of merger and private placement of $117 million
Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction cash of approximately $170 million expected to fu...
November 3, 2023, 7:31 pm
Anika therapeutics, inc. (anik) q3 2023 earnings call transcript
Anika therapeutics, Inc. (NASDAQ:ANIK ) Q3 2023 Earnings Conference Call November 2, 2023 5:30 PM ET Co...
November 3, 2023, 4:34 pm
Korro bio and frequency therapeutics announce closing of merger and private placement of $117 million
Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction cash of approximately $170 million expected to fu...
November 3, 2023, 4:19 pm
Travere therapeutics announces late-breaking data from phase 3 studies of sparsentan in igan and fsgs published in the lancet and the nejm respectively and presented at the american society of nephrol
Two-year results from both PROTECT and DUPLEX pivotal Phase 3 studies demonstrate treatment with sparsentan has the potential to preserve kidney funct...
November 3, 2023, 2:46 pm
Lexeo therapeutics' stock falls 15% in trading debut after its ipo priced below range
Lexeo therapeutics Inc.'s stock LXEO, -15.01% tumbled 15% in its trading debut on Friday, after the com...
November 3, 2023, 12:39 pm
Protara therapeutics announces third quarter 2023 financial results and business update
Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24 Company initiat...
November 3, 2023, 12:00 pm